FDA Inspection 1041263 — Livent USA Corp

Livent USA Corp — FEI 1015213

The FDA completed an inspection of Livent USA Corp on February 16, 2018 in Bessemer City, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 16, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bessemer City, NC (United States)